ArticleCureus2026
Solving a Physiological Conundrum: Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO) as a Bridge Strategy in Severe Acute Respiratory Distress Syndrome (ARDS) Complicated by High-Output Bronchopleural Fistula.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe community-acquired pneumonia (CAP) may lead to complications such as septic shock, acute respiratory distress syndrome (ARDS), empyema, hydropneumothorax, and bronchopleural fistula, creating major therapeutic challenges. In patients with concomitant ARDS and a high-output bronchopleural fistula, the need for lung-protective ventilation may conflict with the reduction in airway pressures required to promote fistula closure. Veno-venous extracorporeal membrane oxygenation (VV-ECMO) may provide a bridge strategy by allowing ultraprotective ventilation while source control and antimicrobial therapy are pursued. We report the case of a 56-year-old man admitted with septic shock secondary to CAP complicated by empyema and hydropneumothorax. On admission, the patient met criteria for severe ARDS, with a PaO₂/FiO₂ ratio of 87 despite a positive end-expiratory pressure (PEEP) of 10 cmH₂O, and refractory hypoxemic and hypercapnic respiratory failure despite prone positioning. A persistent high-output bronchopleural fistula, associated with a continuous air leak of approximately 3 L/min, further compromised ventilatory management. Due to refractory respiratory failure, VV-ECMO was initiated within 24 hours of admission. During hospitalization, pleural cultures identified
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.